| 501 | 35346242 | Hydroxychloroquine attenuates neuroinflammation following traumatic brain injury by regulating the TLR4/NF-κB signaling pathway. | J Neuroinflammation | 2022 Mar 28 |
8 |
| 502 | 35353333 | Combination of doxycycline, streptomycin and hydroxychloroquine for short-course treatment of brucellosis: a single-blind randomized clinical trial. | Infection | 2022 Mar 30 |
1 |
| 503 | 35377866 | A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors. | Melanoma Res | 2022 Jun 1 |
3 |
| 504 | 35386046 | Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS). | Drugs Real World Outcomes | 2022 Jun |
3 |
| 505 | 35401507 | Hydroxychloroquine Alleviates EAU by Inhibiting Uveitogenic T Cells and Ameliorating Retinal Vascular Endothelial Cells Dysfunction. | Front Immunol | 2022 |
5 |
| 506 | 35403913 | Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis: A Retrospective Study. | Arch Immunol Ther Exp (Warsz) | 2022 Apr 11 |
3 |
| 507 | 35411132 | Targets Exploration of Hydroxychloroquine for Pigmentation and Cell Protection Effect in Melanocytes: The Clue for Vitiligo Treatment. | Drug Des Devel Ther | 2022 |
14 |
| 508 | 35443454 | Role of Potential Biomarkers in Management and Prognosis of Corona Virus Disease. | J Assoc Physicians India | 2022 Apr |
1 |
| 509 | 35462097 | Hydroxychloroquine alleviates renal interstitial fibrosis by inhibiting the PI3K/Akt signaling pathway. | Biochem Biophys Res Commun | 2022 Jun 25 |
4 |
| 510 | 35463861 | Antidiabetic effects of hydroxychloroquine in two Japanese patients with systemic lupus erythematosus. | Diabetol Int | 2022 Apr |
1 |
| 511 | 35472798 | Decrease in Visual Acuity in a 77-Year-old Woman with Age-Related Macular Degeneration after a SARS-CoV-2 Infection Treated with Hydroxychloroquine. | Klin Monbl Augenheilkd | 2022 Apr |
1 |
| 512 | 35485606 | Simultaneous proteasome and autophagy inhibition synergistically enhances cytotoxicity of doxorubicin in breast cancer cells. | Cell Biochem Funct | 2022 Jun |
1 |
| 513 | 35499740 | First-Trimester Impetigo Herpetiformis Leads to Stillbirth: A Case Report. | Dermatol Ther (Heidelb) | 2022 May |
1 |
| 514 | 35522252 | Hydroxychloroquine attenuated motor impairment and oxidative stress in a rat 6-hydroxydopamine model of Parkinson's disease. | Int J Neurosci | 2022 May 15 |
1 |
| 515 | 35543153 | D‑allose enhances the efficacy of hydroxychloroquine against Lewis lung carcinoma cell growth by inducing autophagy. | Oncol Rep | 2022 Jun |
2 |
| 516 | 35575468 | Hydroxychloroquine-induced acute generalized exanthematous pustulosis in an orofacial granulomatosis patient with homozygous IL36RN mutation. | Dermatol Ther | 2022 May 16 |
1 |
| 517 | 35578850 | COVID-19 in G6PD-deficient patients, oxidative stress, and neuropathology. | Curr Top Med Chem | 2022 May 16 |
1 |
| 518 | 35628472 | Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels. | Int J Mol Sci | 2022 May 18 |
1 |